SARS-CoV-2 and HIV: Current Perspectives and Challenges

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Virology".

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 468

Special Issue Editors


E-Mail Website
Guest Editor
Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy
Interests: HIV infection; COVID-19; SARS-CoV-2 specific T cell response; SARS-CoV-2 IgG neutralizing antibodies; HIV-specific inflammation; HIV-specific immune activation; microbial translocation

E-Mail Website
Guest Editor
Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy
Interests: HIV infection; COVID-19; post-acute sequelae of SARS-CoV-2 infection HIV-associated neurocognitive disorders; monoclonal antibodies for SARS-CoV-2 infection

E-Mail Website
Guest Editor
Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy
Interests: HIV infection; COVID-19; SARS-CoV-2 specific T cell response; SARS-CoV-2 IgG neutralizing antibodies; HIV-specific inflammation; HIV-specific immune activation; microbial translocation

Special Issue Information

Dear Colleagues,

Given their increased risk of severe complications following common respiratory viral infections, such as influenza, HIV-positive patients were initially thought to be at increased risk of a more severe course of SARS-CoV-2 infection.

However, the first studies failed to demonstrate an increased risk of SARS-COV-2 infection and of severe clinical course in HIV-infected patients. As regards immunological response to natural infection or to vaccination, however, other preliminary studies describe a lower total SARS-CoV-2 specific IgG neutralizing antibody concentrations following natural infection and dysfunctional vaccine response in persons living with HIV.

The aim of this Special Issue of Microorganisms is to better describe the clinical course of COVID-19, the innate and acquired immune response to SARS-CoV-2 infection and the humoral response to COVID-19 vaccination in HIV-positive patients, compared to HIV-negative controls. Articles that describe aspects of SARS-CoV-2 specific immune response following natural infection and the available vaccines in HIV-positive patients are particularly sought.

The manuscripts included in this Special Issue should provide a larger and more detailed overview of the magnitude, functionality, and durability of the immune responses to SARS-CoV-2 infection, as well as inform strategies of targeted therapeutic interventions and vaccine schedules, in HIV-infected individuals.

Prof. Dr. Giulia Marchetti
Dr. Francesca Bai
Dr. Roberta Rovito
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • HIV infection
  • SARS-CoV-2 infection
  • HIV/SARS-CoV-2 coinfection
  • post-acute sequelae of SARS-CoV-2 infection
  • SARS-CoV-2 IgG neutralizing antibodies
  • antibody and memory B cell response following COVID-19 vaccination

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop